Murphy Keith

Avg. Two Year Performance

(67%) Avg. Purchase Return
(29%) Compound
72% Avg. Sale Return
31% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(2%)(25%)21%(22%)(67%)
Purchase Success Rate1 of 21 of 21 of 21 of 20 of 2
Average Sale Return(10%)7%24%36%72%
Sale Success Rate3 of 54 of 54 of 54 of 55 of 5

Organovo Holdings, Inc.

Health Services » Medical Laboratories & Research

Executive Chairman, Director:

Holdings: 132.64K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Del Mar Pharmaceuticals Inc.

Drugs » Biotechnology

Director:

Holdings: 181.01K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--